Go to main content

Reform to the Amparo Law

March 13, 2025 /

On March 13, 2025, the reform to the Amparo Law was published in the Official Gazette of the Federation, in order to continue the so-called constitutional reform of the Federal Judicial Branch.

The reforms to the Amparo Law do not modify, alter, or substantially change the amparo trial, its admissibility requirements, its procedure, or the matters that may be challenged.

Although the reform encompassed multiple articles, it focused on changing the law's language to give it a broader gender perspective; this constitutes the majority of the changes made by Congress.

Additionally, to continue the constitutional reform, all references to the Chambers of the Supreme Court of Justice of the Nation were removed, having been eliminated in the constitutional reform, and the majority voting power on matters in the Supreme Court Plenary was adjusted to reflect the fact that it will be composed of nine justices. Likewise, the provision that amparos against general norms cannot have general effects was incorporated into the text of the Amparo Law, a provision that had already been incorporated into the Constitution.

On the other hand, the amounts of fines that can be imposed by judges have been increased.

It should be noted that the reforms to the Amparo Law did not modify the conditions for filing amparo claims or for obtaining the suspension of the effects of the contested act; nor did they change the time limits and terms applicable to amparo trials. Therefore, the reform maintained the trial process intact and focused solely on making adjustments to bring the Amparo Law into line with the reform of the Federal Constitution.

Related articles

Santamarina Steta Law for the Promotion of Investment in Infrastructure

The Regulations of the Law for the Promotion of Investment are issued…

On May 8, 2026, the Decree issuing the Regulations (hereinafter, the “Regl…) was published in the Official Gazette of the Federation
Santamarina Steta Guidelines for the promotion of investment in the pharmaceutical and health supplies industry

Guidelines for promoting investment in the industry…

KEY ASPECTS On May 21, 2026, the Ministry of Health published in the Official Gazette of the Federation the “Guidelines for the Pr…
Santamarina Steta NOM 137 SSA1 2025 New labeling framework for devices

NOM-137-SSA1-2025: New labeling framework for devices…

On May 19, 2026, the Ministry of Health, through the Federal Commission for Protection against Sanitary Risks (“COFEPRIS”)…